Contineum Therapeutics In... (CTNM)
4.59
0.21 (4.79%)
At close: Apr 17, 2025, 3:59 PM
4.62
0.54%
After-hours: Apr 17, 2025, 04:05 PM EDT
Contineum Therapeutics Class A Common Stock Revenue
Contineum Therapeutics Class A Common Stock reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending December 31, 2024, Contineum Therapeutics Class A Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
41
Market Cap
118.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 0 | -100.00% |
| Dec 31, 2023 | 50M | +Infinity% |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |